Literature DB >> 6878107

Juvenile proximal spinal muscular atrophy with early hypertrophy of calves.

J M Gobernado, C Riva, A Gimeno, E García-Albea, A Anaya.   

Abstract

The clinical, electrophysiological, histological and ultrastructural features of a patient with chronic spinal muscular atrophy of adolescent onset associated with hypertrophied calf-muscle are described. This recently recognised entity must be distinguished from other types of spinal muscular atrophy.

Entities:  

Mesh：

Year:  1983        PMID： 6878107      PMCID： PMC2417408          DOI： 10.1136/pgmj.59.691.327

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  7 in total

1.  Heredofamilial juvenile muscular atrophy simulating muscular dystrophy.

Authors:  E KUGELBERG; L WELANDER
Journal:  AMA Arch Neurol Psychiatry       Date:  1956-05

2.  Hereditary proximal spinal muscular atrophy, a clinical entity simulating progressive muscular dystrophy.

Authors:  G WOHLFART; J FEX; S ELIASSON
Journal:  Acta Psychiatr Neurol Scand       Date:  1955

3.  The Ryukyuan muscular atrophy. An obscure heritable neuromuscular disease found in the islands of southern Japan.

Authors:  K Kondo; T Tsubaki; F Sakamoto
Journal:  J Neurol Sci       Date:  1970-10       Impact factor: 3.181

4.  Chronic proximal spinal muscular atrophy.

Authors:  T Namba; D C Aberfeld; D Grob
Journal:  J Neurol Sci       Date:  1970-11       Impact factor: 3.181

5.  Classification of spinal muscular atrophies.

Authors:  J Pearn
Journal:  Lancet       Date:  1980-04-26       Impact factor: 79.321

6.  Microcephaly and mental subnormalitiy in chronic progressive spinal muscular atrophy of childhood.

Authors:  A J Spiro; M H Fogelson; A C Goldberg
Journal:  Dev Med Child Neurol       Date:  1967-10       Impact factor: 5.449

7.  Anterior-horn cell degeneration and gross calf hypertrophy with adolescent onset. A new spinal muscular atrophy syndrome.

Authors:  J Pearn; P Hudgson
Journal:  Lancet       Date:  1978-05-20       Impact factor: 79.321
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.